AzTrials
AzTrials

Concussion, BrainNeuropsyCorNCT05719844

Interest of an Attentional Evaluation by a Computerized Battery in the Management of Concussion in Young Rugby Players

A study testing Neuropsychological tests in people with Concussion, Brain, run by University Hospital, Clermont-Ferrand at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this study is to test the ability of a computerized neuropsychological battery to identify attentional disorders resulting from a concussion occurring during the practice of rugby. Thirty young people with a concussion (11-25 years old) will take several neuropsychological tests. Read more about this study

Who is it for?
Ages 11 to 25 years, men onlyHealthy volunteers can take part
Conditions the study is for
Concussion, Brain
What is being tested?
Neuropsychological tests
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteFrance
Study dates
9 Mar 2023to 9 Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 25 years
  • Men only
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Patients :
  • concussion in the context of the practice of rugby
  • French or reading French without help
  • Controls :
  • no concussion
  • practicing a non-contact sport (athletics, rowing, badminton, capoeira, circus, running, crossfit, cycling, dancing, climbing, fencing, fitness, golf, gymnastics, bodybuilding, swimming, skating, Qi Gong, Taï chi, tennis, table tennis, shooting, trail running, volleyball, water polo) within a sports association
Show all 9Show fewer
  • age matched to patient (+/- 1 year)
  • study level matched to patient (+/- 1 year)
  • French or reading French without help

Who cannot join

  • Patients :
  • Legal protection measure
  • Other neurological or psychiatric pathologies prior to concussion episodes
  • Diagnosis of a neurodevelopmental disorder in childhood
  • Score less than or equal to 5/19 on the "Matrix" subtest (intellectual retardation)
  • Addictive behaviors
Show all 17Show fewer
  • Current major depressive disorder or treated with antidepressants or benzodiazepines for less than 3 months
  • Severe visual or motor problems that may interfere with the performance of the tests
  • Controls :
  • Legal protection measure
  • History of proven concussion
  • Other neurological or psychiatric pathologies
  • Diagnosis of a neurodevelopmental disorder in childhood
  • Score less than or equal to 5/19 on the "Matrix" subtest (intellectual retardation)
  • Addictive behaviors
  • Current major depressive episode or treated with antidepressants or benzodiazepines for less than 3 months
  • Severe visual or motor problems that may interfere with the performance of the tests

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • CHU de Clermont-Ferrand

    Clermont-Ferrand, 63000

    Lise Laclautre, +33473754963, promo_interne_drci@chu-clermontferrand.fr

    Recruiting

Other trials in France

About this study

The goal of this study is to test the ability of a computerized neuropsychological battery to identify attentional disorders resulting from a concussion occurring during the practice of rugby. Thirty young people with a concussion (11-25 years old) will take several neuropsychological tests. Researchers will compare their results with those of young athletes without concussion to see the effect of concussion.

Read the detailed description

The objective is to carry out a complete neuropsychological assessment, detailing the attentional and executive aspects using the TAP computerized battery. In addition, various paper-and-pencil tests, standardized in French, more commonly used in the context of neuropsychological data related to concussions in athletes, will also be administered. These assess processing speed, short-term memory and auditory-verbal working memory capacity, episodic memory and selective attention. This preliminary study would make it possible to shed light on the links that may exist between performance in the various tests proposed and the characteristics inherent in the symptomatology of concussion. Furthermore, it seems relevant to compare the results of computerized tests with other paper-and-pencil tests but also with the performance of individuals who have no history of concussion with the practice of a non-contact sport.

The results of this study would make it possible in practice to have a neuropsychological assessment more specific to cerebral concussion, with a potentially reduced consultation time due to the use of more sensitive tools, and therefore, an earlier rehabilitative intervention.

Being tested
Neuropsychological tests
Medical subject headings
Brain Concussion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Neuropsychological testsDiagnostic test

    List of neuropsychological tests:

    • Matrix reasoning
    • D2-R
    • Coding
    • Symbol search
    • Digit span
    • Alertness (computerized TAP battery)
    • Divided Attention (computerized TAP battery)
    • Go / No go (computerized TAP battery)
    • Incompatibility (computerized TAP battery)
    • Working memory (computerized TAP battery)
    • 16-item Free and Cued Recall or Stories subtest of the Children Memory Scale (CMS) for children only (< 17 years old)
    • complex figure of the memory efficiency battery 144 or Word pairs of the Children Memory Scale for children only (< 17 years old)
Study groups in NCT05719844
Study groupRoleWhat they receive
Neuropsychological testsExperimentalThe neuropsychological tests are computerized (TAP battery) or paper-and-pencil tests. They assess processing speed, short-term memory and auditory-verbal working memory capacity, episodic memory and selective attention.
Receives: Diagnostic Test: Neuropsychological tests

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Alertness time

    Reaction time (ms) in the Alertness TAP test

    Measured: At inclusion

  2. Alertness error

    Number of errors in the Alertness TAP test

    Measured: At inclusion

  3. Divided Attention time

    Reaction time (ms) in the Divided Attention TAP test

    Measured: At inclusion

  4. Divided Attention error

    Number of errors in the Divided Attention TAP test

    Measured: At inclusion

  5. Go/No-go time

    Reaction time (ms) in the Go/No-go TAP test

    Measured: At inclusion

  6. Go/No-go error

    Number of errors in the Go/No-go TAP test

    Measured: At inclusion

  7. Incompatibility time

    Reaction time (ms) in the Incompatibility TAP test

    Measured: At inclusion

  8. Incompatibility error

    Number of errors in the Incompatibility TAP test

    Measured: At inclusion

  9. Working Memory time

    Reaction time (ms) in the Working Memory TAP test

    Measured: At inclusion

  10. Working Memory error

    Number of errors in the Working Memory TAP test

    Measured: At inclusion

Secondary outcomes (17)
  1. Matrix reasoning

    Number of errors in Matrix reasoning test

    Measured: At inclusion

  2. Coding

    Number of errors in coding test

    Measured: At inclusion

  3. Symbol

    Number of errors symbol search test

    Measured: At inclusion

  4. Digit span

    Number of errors in digit span test

    Measured: At inclusion

  5. 16-item free and cued recall

    Number of recall words in 16-item free and cued recall test

    Measured: At inclusion

  6. Complex figure

    Score in the complex figure of the memory efficient battery 144. Score is determined by the number of elements of the figure recalled.

    Measured: At inclusion

  7. Stories

    Number of errors in stories subtests of the Child Memory Scale (CMS)

    Measured: At inclusion

  8. Word pairs

    Number of errors in word pairs subtests of the Child Memory Scale (CMS)

    Measured: At inclusion

  9. D2-R error

    Number of errors in D2-R tests

    Measured: At inclusion

  10. D2-R time

    Time (in seconds) to complete the D2-R test

    Measured: At inclusion

  11. Sociodemographic data

    age and level of study of participants

    Measured: At inclusion

  12. Headaches

    Presence or absence of headaches

    Measured: At inclusion

  13. Amnesia

    Presence of anterograde or retrograde amnesia

    Measured: At inclusion

  14. SCAT

    Symptom severity score on the Sport Concussion Assessment Tool (SCAT), range 0-132 (minimum-maximum), a higher score representing a more severe concussion

    Measured: At inclusion

  15. Sleep

    Change in sleep (presence of hyper or insomnia)

    Measured: At inclusion

  16. Consciousness

    Loss of initial consciousness or not

    Measured: At inclusion

  17. Position

    Player position in the rugby team

    Measured: At inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Feb 2023
  2. Study start9 Mar 2023
  3. Primary completion9 Mar 2027 (estimated)
  4. Study completion9 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05719844
Sponsor's protocol ID
AOI 2021 VIDAL
Acronym
NeuropsyCor
Status last verified
Apr 2026
First submitted
17 Jan 2023
Last updated
30 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Neuropsychological tests in people with Concussion, Brain, run by University Hospital, Clermont-Ferrand at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Lise LACLAUTRE (+334.73.754.963, promo_interne_drci@chu-clermontferrand.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Alertness time (time frame: At inclusion). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in